TileDB Recognized in Two 2025 Gartner® Hype Cycle™ Reports for Healthcare and Life Sciences

Database technology company positioned as key enabler for 'Trusted Research Environments' and 'Single-Cell Multiomics Systems'

CAMBRIDGE, Mass., July 24, 2025 /PRNewswire/ -- TileDB, the multimodal database pioneer, has been recognized as a Sample Vendor in two Gartner Hype Cycle reports: Hype Cycle for Life Science R&D, 2025 and Hype Cycle for Healthcare and Life Science Data, Analytics and AI, 2025. The company was identified in both Trusted Research Environments and Single-Cell Multiomics Systems, two emerging technology areas that Gartner rated as having "high" Benefit Rating for the industry.

We believe, TileDB's inclusion in multiple categories underscores the platform's versatility in addressing critical data infrastructure challenges across the life sciences research continuum. Both categories represent emerging technologies positioned to reach mainstream adoption within the next 5-10 years.

Trusted Research Environments (Market Penetration: 5-20% | Maturity: Emerging)
Gartner defines "trusted research environments are scalable and secure healthcare research platforms that provide a collection of capabilities for the evolving needs of research institutions. These include multimodal data management and sharing, differential user access, data and algorithmic marketplaces, standards-based ontologies, data enrichment, hybrid cloud, MLOps, and collaboration tools."

Single-Cell Multiomics Systems (Market Penetration: 1-5% | Maturity: Emerging)
This category encompasses technologies that enable analysis of multiple "omics" datasets at the single-cell level, providing unprecedented insights into cellular heterogeneity and disease mechanisms to accelerate precision medicine.

"We believe Gartner's Hype Cycle recognition validates our mission to give data practitioners the power to conduct complex data management and analytics that are foundational to discoveries in healthcare and life sciences," said Stavros Papadopolous, Founder and CEO at TileDB. "Our platform's ability to handle massive, multi-dimensional datasets generated by modern research—from genomics to spatial biology—positions us uniquely to support the next generation of scientific discovery."

Addressing Critical Industry Challenges

The Gartner report identifies several key trends driving technology adoption in life sciences R&D:

• Data-intensive discovery: "Advances in single-cell and spatial omics, coupled with ever-larger imaging and phenotypic datasets, are underpinning demand for scalable analytics and AI-driven hypothesis generation."
• Cost and time pressures: Organizations need cloud-native platforms that accelerate research while reducing infrastructure costs
• Regulatory compliance: Secure, compliant data management is essential for regulated research environments

TileDB's omnimodal database architecture directly addresses these challenges by providing high-performance storage and analysis capabilities for sparse, multi-dimensional datasets while maintaining the security and governance requirements of regulated research environments.

According to Gartner's analysis, both technology categories are positioned in the "Emerging" maturity phase, which we believe represents an inflection point where early adopters can gain significant competitive advantages. The reports note that healthcare and life sciences organizations are "fast-tracking AI, multiomics, cloud, and digital-trial platforms to sharpen competitive differentiation and drive R&D efficiency."

"To us, the recognition in these two complementary areas reflects TileDB's comprehensive approach to scientific data management," said Seth Shelnutt, CTO at TileDB. "Whether researchers are building trusted collaborative platforms for multi-institutional studies or analyzing single-cell datasets with billions of data points, TileDB provides the foundation for breakthrough discoveries."

Gartner, Hype Cycle for Healthcare and Life Science Data, Analytics and AI, 2025, 7 July 2025

Gartner, Hype Cycle for Life Science R&D, 2025, 7 July 2025

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

GARTNER and HYPE CYCLE are registered trademarks of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved.

About TileDB

TileDB is the multimodal database designed for discovery. Unlike traditional cloud database management solutions, TileDB accelerates the analysis of complex multimodal data such as genomics, proteomics, single-cell, and bioimaging using multi-dimensional arrays. With TileDB, users can organize, structure, collaborate, and analyze multimodal data in one platform, to accelerate breakthroughs in the life sciences and beyond.

For more information about TileDB's solutions for healthcare and life sciences, visit tiledb.com.

For inquiries -- Julie Bryce for TileDB [email protected] 919-414-1052 

SOURCE TileDB